Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6823898 | Schizophrenia Research | 2015 | 7 Pages |
Abstract
Clozapine was used in one-third of schizophrenia patients in China, with decreasing frequency since 2002. Patients prescribed clozapine had multiple markers of greater global illness severity/chronicity and decreased satisfaction with treatment by the families, but similar QOL and less delusions and hallucinations than patients not prescribed clozapine.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Qian Li, Yu-Tao Xiang, Yun-Ai Su, Liang Shu, Xin Yu, Christoph U. Correll, Gabor S. Ungvari, Helen F.K. Chiu, Cui Ma, Gao-Hua Wang, Pei-Shen Bai, Tao Li, Li-Zhong Sun, Jian-Guo Shi, Xian-Sheng Chen, Qi-Yi Mei, Ke-Qing Li, Tian-Mei Si, John M. Kane,